http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014112114-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9c55cbd632f124625c19c848aaffd9c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 |
| filingDate | 2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf29589a5bfd893216eaeae37e7a0f9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22728243472b6b29c763b9358cbcc6b |
| publicationDate | 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014112114-A |
| titleOfInvention | Platelet aggregation assay |
| abstract | A method for determining platelet aggregation, a method for determining susceptibility to coagulation upon administration of a CD40L binding moiety, and kits related thereto. A method for assaying platelet aggregation comprising contacting platelets with a platelet activating factor; contacting the activated platelets with a CD40L binding moiety; and cross-linking the activated platelets. Contacting the factor, wherein the CD40L binding moiety and the cross-linking factor are not preformed immune complexes and the precipitated platelets are indicative of aggregation of the platelets. [Selection figure] None |
| priorityDate | 2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.